Founder Of Medsol Kathryn Malherbe Launches Software For Breast Cancer Identification
Founder Of Medsol Kathryn Malherbe Launches Software For Breast Cancer Identification. South African entrepreneur and founder of Medsol Kathryn Malherbe has announced that her company is developing a artificial intelligence software that will be able to identify breast cancer.
“Our software is mobile and hands free, and is ideal for rural based institutions wanting to improve their diagnostic output,” Malherbe told the SAB Foundation. “Women living in rural areas experience higher false-positive cancer rates on diagnostic mammography. They also have lower screening mammography uptake and more advanced stage cancer at diagnosis.”
Medsol Breast AI is an online patient based platform that receives images for ultrasound units in practice. The images are then fed into a unique system that identifies any abnormal breast cancer masses. The product focuses on patient-based outcomes, with a unique educational platform for patients diagnosed with breast cancer to ensure they are informed and empowered with the necessary information going forward during their treatment journey.
“We employ breast cancer survivors as ambassadors to promote breast education. This boosts the local economy by creating jobs and also helps to break the stigma associated with this disease,” Malherbe added. “Since starting our ambassador campaign in 2020, we have employed over 25 women across the country, and have educated and supported over 122 000 women on our online platform. We are now looking to expand to Tanzania, Zambia and Namibia.”
MedSol strives to be a share-value multifaceted partner in the healthcare sector, answering the call to provide pioneering market leading care to medical practitioners and patients through an unrivalled quality, surpassed only by the trust earned with each transaction. MedSol is a proud member of the CompSol Group which is renowned for service excellence in the healthcare sector.
Malherbe has managed to create something that will have a significant positive impact on how breaths cancer is detected. This will help most women in Africa to identify breast cancer early and therefore be able to treat it early.
